DoxorubicinRazoxaneAntibiotics, AntineoplasticHeart DiseasesHeartCardiomyopathiesCardiotoxinsMyocytes, CardiacMyocardiumAnthracyclinesHydroxyethylrutosideAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDaunorubicinCyclophosphamideVincristineEpirubicinDexrazoxaneCardiotonic AgentsBreast NeoplasmsDose-Response Relationship, DrugLiposomesMitoxantroneDrug CarriersDrug Administration SchedulePrednisoneApoptosisPaclitaxelDrug Resistance, NeoplasmVentricular Function, LeftFluorouracilEthyl EthersPolyethylene GlycolsNeoplasmsAntibodies, Monoclonal, HumanizedMitochondria, HeartCell Line, TumorButylaminesP-GlycoproteinTreatment OutcomeElectrocardiographyVentricular Dysfunction, LeftTime FactorsDrug-Related Side Effects and Adverse ReactionsCisplatinCreatine KinaseCell SurvivalHeart FailureDrug Evaluation, PreclinicalDrug SynergismNaphthacenesDrug Resistance, MultipleSarcomaEchocardiographyIdarubicinDrug InteractionsEtoposideTroponin ITaxoidsVinblastineCyclooctanesReactive Oxygen SpeciesOxidative Stress